Elisa Grassi

1.0k total citations
49 papers, 629 citations indexed

About

Elisa Grassi is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Elisa Grassi has authored 49 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 18 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Elisa Grassi's work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Glioma Diagnosis and Treatment (5 papers). Elisa Grassi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Glioma Diagnosis and Treatment (5 papers). Elisa Grassi collaborates with scholars based in Italy, Sweden and Belgium. Elisa Grassi's co-authors include Alexander Pietras, Luca Persani, Vasiliki Pantazopoulou, Tracy J. Berg, Giovanni Vitale, Bei Tong, David Lindgren, S. Ardizzone, María Orietta Borghi and Håkan Axelson and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Elisa Grassi

46 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Grassi Italy 16 274 245 159 105 98 49 629
Eftychia Oikonomou Greece 13 273 1.0× 330 1.3× 135 0.8× 67 0.6× 69 0.7× 16 597
Alexandre Arcaro Switzerland 14 195 0.7× 393 1.6× 209 1.3× 53 0.5× 80 0.8× 20 606
Natalie Burrows United Kingdom 16 150 0.5× 337 1.4× 211 1.3× 98 0.9× 50 0.5× 38 789
Teresa Gagliano Italy 15 200 0.7× 297 1.2× 149 0.9× 83 0.8× 74 0.8× 36 615
Jeffrey Chen United States 6 195 0.7× 384 1.6× 91 0.6× 51 0.5× 91 0.9× 11 712
Reema S. Wahdan-Alaswad United States 12 310 1.1× 531 2.2× 246 1.5× 47 0.4× 70 0.7× 17 692
Jinxiang Tan China 14 208 0.8× 429 1.8× 253 1.6× 51 0.5× 81 0.8× 21 818
Letícia Ferro Leal Brazil 17 212 0.8× 399 1.6× 296 1.9× 105 1.0× 198 2.0× 61 882
Tao Hai China 12 107 0.4× 314 1.3× 234 1.5× 94 0.9× 35 0.4× 17 523

Countries citing papers authored by Elisa Grassi

Since Specialization
Citations

This map shows the geographic impact of Elisa Grassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Grassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Grassi more than expected).

Fields of papers citing papers by Elisa Grassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Grassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Grassi. The network helps show where Elisa Grassi may publish in the future.

Co-authorship network of co-authors of Elisa Grassi

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Grassi. A scholar is included among the top collaborators of Elisa Grassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Grassi. Elisa Grassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grassi, Elisa, et al.. (2024). Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model. Cancer Cell International. 24(1). 196–196. 2 indexed citations
2.
Muzza, Marina, Carla Colombo, Elisa Grassi, et al.. (2024). Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma. Translational research. 271. 1–12. 3 indexed citations
3.
Gentilini, Davide, Marina Muzza, Tiziana de Filippis, et al.. (2022). Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism. Journal of Endocrinological Investigation. 46(2). 393–404. 2 indexed citations
4.
Cirello, Valentina, Elisa Grassi, Marina Muzza, et al.. (2022). FAM83B is involved in thyroid cancer cell differentiation and migration. Scientific Reports. 12(1). 8608–8608. 3 indexed citations
5.
Grassi, Elisa, et al.. (2021). Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer. Frontiers in Oncology. 11. 601722–601722. 34 indexed citations
6.
Dicitore, Alessandra, Maria Giulia Bacalini, Germano Gaudenzi, et al.. (2021). Role of Epigenetic Therapy in the Modulation of Tumor Growth and Migration in Human Castration-Resistant Prostate Cancer Cells with Neuroendocrine Differentiation. Neuroendocrinology. 112(6). 580–594. 3 indexed citations
7.
8.
Grassi, Elisa, Pauline Jeannot, Vasiliki Pantazopoulou, Tracy J. Berg, & Alexander Pietras. (2020). Niche-derived soluble DLK1 promotes glioma growth. Neoplasia. 22(12). 689–701. 12 indexed citations
9.
Grassi, Elisa, Vasiliki Pantazopoulou, & Alexander Pietras. (2020). Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma. Oncogene. 39(20). 4028–4044. 24 indexed citations
10.
Marco, Mariacristina Di, Riccardo Carloni, Stefania De Lorenzo, et al.. (2020). Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report. World Journal of Gastrointestinal Oncology. 12(12). 1456–1463. 2 indexed citations
11.
Grassi, Elisa, Andrea Palloni, Riccardo Carloni, et al.. (2020). Searching for novel multimodal treatments in oligometastatic pancreatic cancer. BMC Cancer. 20(1). 271–271. 5 indexed citations
12.
Arcelli, A., A. Guido, Milly Buwenge, et al.. (2019). Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Anticancer Research. 40(1). 465–472. 33 indexed citations
13.
Buwenge, Milly, Gabriella Macchia, A. Arcelli, et al.. (2018). Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief. Journal of Pain Research. Volume 11. 2169–2178. 45 indexed citations
14.
Cirello, Valentina, Germano Gaudenzi, Elisa Grassi, et al.. (2018). Tumor and normal thyroid spheroids: from tissues to zebrafish. Minerva Endocrinology. 43(1). 1–10. 12 indexed citations
15.
Dicitore, Alessandra, Elisa Grassi, María Orietta Borghi, et al.. (2017). Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation. Journal of Endocrinological Investigation. 40(7). 761–770. 10 indexed citations
16.
Grassi, Elisa, Vasiliki Pantazopoulou, Bei Tong, et al.. (2017). CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. Cell Reports. 20(7). 1641–1653. 88 indexed citations
17.
Grassi, Elisa, et al.. (2016). 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth. Endocrine. 56(2). 388–398. 1 indexed citations
18.
Dicitore, Alessandra, Elisa Grassi, Michele Caraglia, et al.. (2015). The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines. Endocrine. 51(1). 101–112. 19 indexed citations
19.
Grassi, Elisa, Gunnar Kleinau, Heike Biebermann, et al.. (2015). Loss-of-Function Variants in a Hungarian Cohort Reveal Structural Insights on TSH Receptor Maturation and Signaling. The Journal of Clinical Endocrinology & Metabolism. 100(7). E1039–E1045. 17 indexed citations
20.
Lucchi, Simona, Davide Calebiro, Tiziana de Filippis, et al.. (2011). 8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms. PLoS ONE. 6(6). e20785–e20785. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eftychia Oikonomou Breakdown of academic impact, for papers by Alexandre Arcaro Breakdown of academic impact, for papers by Natalie Burrows Breakdown of academic impact, for papers by Teresa Gagliano Breakdown of academic impact, for papers by Jeffrey Chen Breakdown of academic impact, for papers by Reema S. Wahdan-Alaswad Breakdown of academic impact, for papers by Jinxiang Tan Breakdown of academic impact, for papers by Letícia Ferro Leal Breakdown of academic impact, for papers by Tao Hai
Rankless by CCL
2026